Life Science Scoop | Medical | October 2023
Camilla Fedi
Medical Affairs and Clinical Development Recruiter |90% CV to interview ratio| Biotech, Pharma, and CROs | USA & Canada
As we step into a new month, we're back with the latest in the pharmaceutical and biotech industries. From groundbreaking clinical trials to fresh scientific discoveries, your updates are covered. I am so sorry for missing last month's issue, I was away on holiday after finishing a large project.
But that's not all. If you're a driven professional seeking opportunities in Medical Affairs and Clinical Development, we have exciting job openings to explore. It's quite a number of them this month, so make sure to scroll all the way!
In this edition, we're also featuring an outstanding candidate we've been working with closely. If your team is ready for an exceptional addition, reach out to us today.
Open Opportunities
Medical Director, Medical Affairs - Neurology Biopharma- Up to 250,000- EST
Candidate Highlight
A highly skilled physician and Associate Director of Medical Affairs, with experience in Neurology, Psychiatry and Nephrology is looking for a lateral move within Med Affairs or late-phase Clin Dev.
#talentacquisition ?Managers, Executives, and Chief Professionals: If you would like to know more about this profile, or, if you are currently seeking an expert to efficiently hire top?#medicalaffairs ?and?#clinicaldevelopment ?Senior talent, kindly reach out to me or send an email to:?[email protected] .
What to Read
Regeneron and Sanofi become hopeful as the FDA accepts their supplemental biologics license application for EoE
This morning, the FDA officially accepted Regeneron and Sanofi's sBLA, in which they requested authorization for Dupixent to be used in the treatment of Eosinophilic Esophagitis (EoE) specifically in children under 11 years old.
Eosinophilic esophagitis (EoE) is a rare autoimmune disease characterized by the accumulation of eosinophils in the oesophagus, leading to inflammation and damage to the digestive system. This condition has only recently been discovered, and currently, Dupixent is the sole available treatment option.
However, its approval has been limited to adults. The FDA has set a target date of January 31, 2024, for a comprehensive review of the application and a response
领英推荐
Read the full article: https://pharmafile.com/news/regeneron-and-sanofis-sbla-for-dupixent-accepted-by-fda-for-priority-review/
Sudafed to be pulled from the counters after the FDA stated "It just doesn't work"
Sudafed is at the moment the only oral decongestant available over the counter, without prescription. It accounts for almost 2 billion in sales annually, with half of American households purchasing Sudafed at least once a year. It has been used for decades to treat allergies and common cold symptoms but apparently, it was all invane.
The reevaluation of Sudafed safety and efficacy has been a long process, starting back in 2007. In the last 15 years, the FDA has evaluated 4 additional clinical trials, as well as the original one that granted approval back in the day. In all 5 trials, they found major issues with the trial design, endpoints, and efficacy of the product.
This has led the FDA to recall the previous "safe and effective" designation granted to the Sudafed active principle. Will this change how we treat common colds? The OTC aisle at the drugstore is definitely going to change looks!
Who are we?
Warman O'Brien is a global Life Sciences Recruitment partner. We're proud to say that we have a 90% success rate of CV-to-interview matches, and our partnerships with pioneering?#Biotech ,?#Pharma , and?#CROs ?across the USA, UK, and Europe. We recruit top talent across multiple functional areas, including?#Biometrics ,?#DataScience ,?#QualityAssurance ,?#RegulatoryAffairs ,?#ClinicalResearch ,?#DiscoverySciences , and?#Medical .
Watch a brief video about our expertise in the US and Canada, why we love what we do and how can we help your organization!
Within Medical, I specialize in Senior Positions across Medical Affairs and Clinical Development, partnering with numerous biotech, pharma, and CRO companies on the USA East Coast.
Is this not exactly what you are looking for? Check out our new?website ?for all of the other positions available!
Follow me on Linkedin ?for daily updates and be the first to apply for the hottest jobs of the week!